Medicare Enrolled

Dr. Christopher Renzi

Nurse Practitioner - Family · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1324 W RITNER ST, Philadelphia, PA 19148
2677737311
In practice since 2016 (9 years)
NPI: 1285179390 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Renzi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Renzi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Renzi

Dr. Christopher Renzi is a nurse practitioner - family in Philadelphia, PA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Renzi performed 731 Medicare services across 279 unique beneficiaries.

Between the years covered by Open Payments, Dr. Renzi received a total of $13,672 from 61 pharmaceutical and/or device companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Renzi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 10% volume in PA $13,672 industry payments

Medicare Practice Summary

Medicare Utilization ↗
731
Medicare services
Top 10% in PA for nurse practitioner - family
279
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
491 $52 $125
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
125 $12 $75
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
38 $32 $35
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
35 $72 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $55 $160
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $62 $175
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
12 $1 $24
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,672
Total received (2021-2024)
Avg $3,418/year across 4 years
Top 1% in PA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
762
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,436 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$236 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,107
2023
$3,150
2022
$3,041
2021
$3,374

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$672
AstraZeneca Pharmaceuticals LP
$452
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$435
Novo Nordisk Inc
$269
Otsuka America Pharmaceutical, Inc.
$193
Lilly USA, LLC
$188
Lundbeck LLC
$167
Neurocrine Biosciences, Inc.
$163
GlaxoSmithKline, LLC.
$160
Collegium Pharmaceutical, Inc.
$145
Astellas Pharma US Inc
$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$113
Amgen Inc.
$108
Sumitomo Pharma America, Inc.
$95
Novartis Pharmaceuticals Corporation
$85
Takeda Pharmaceuticals U.S.A., Inc.
$80
Valinor Pharma, LLC
$69
AIMMUNE THERAPEUTICS, INC.
$64
Xeris Pharmaceuticals, Inc.
$64
Indivior Inc.
$62
Alkermes, Inc.
$60
PFIZER INC.
$52
Daiichi Sankyo Inc.
$51
Phathom Pharmaceuticals, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$36
Paratek Pharmaceuticals, Inc.
$35
Tolmar, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
Hologic Sales and Service, LLC
$24
Braeburn Inc.
$20
Kowa Pharmaceuticals America, Inc.
$17
Top 3 companies account for 37.9% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,567
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,312
Novo Nordisk Inc
$1,264
AstraZeneca Pharmaceuticals LP
$1,242
GlaxoSmithKline, LLC.
$1,002
Lilly USA, LLC
$533
Janssen Pharmaceuticals, Inc
$429
Astellas Pharma US Inc
$423
Otsuka America Pharmaceutical, Inc.
$363
AbbVie Inc.
$333
Lundbeck LLC
$325
Boehringer Ingelheim Pharmaceuticals, Inc.
$309
Novartis Pharmaceuticals Corporation
$302
Takeda Pharmaceuticals U.S.A., Inc.
$295
Collegium Pharmaceutical, Inc.
$265
Amgen Inc.
$253
PFIZER INC.
$214
Xeris Pharmaceuticals, Inc.
$206
Indivior Inc.
$203
Daiichi Sankyo Inc.
$191
Neurocrine Biosciences, Inc.
$186
Horizon Therapeutics plc
$144
E.R. Squibb & Sons, L.L.C.
$131
RedHill Biopharma Inc.
$122
Paratek Pharmaceuticals, Inc.
$118
Merck Sharp & Dohme LLC
$117
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$113
Orexo US, Inc.
$111
Alkermes, Inc.
$100
Sumitomo Pharma America, Inc.
$95
Kowa Pharmaceuticals America, Inc.
$91
Valinor Pharma, LLC
$88
Almatica Pharma LLC
$82
Tolmar, Inc.
$73
Abbott Laboratories
$71
Merck Sharp & Dohme Corporation
$68
Biohaven Pharmaceutical Holding Company Ltd.
$66
AIMMUNE THERAPEUTICS, INC.
$64
Bayer Healthcare Pharmaceuticals Inc.
$61
Amarin Pharma Inc.
$56
Nestle HealthCare Nutrition Inc.
$50
Eisai Inc.
$49
Bayer HealthCare Pharmaceuticals Inc.
$48
Corium, LLC
$47
Biohaven Pharmaceuticals, Inc.
$46
Phathom Pharmaceuticals, Inc.
$44
ITI, Inc.
$40
Genentech USA, Inc.
$38
NESTLE HEALTHCARE NUTRITION INC.
$37
Supernus Pharmaceuticals, Inc.
$31
ARBOR PHARMACEUTICALS, INC.
$31
Exact Sciences Corporation
$31
Hologic Sales and Service, LLC
$24
Evoke Pharma, Inc.
$23
SANOFI-AVENTIS U.S. LLC
$22
Teva Pharmaceuticals USA, Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$20
Braeburn Inc.
$20
Corcept Therapeutics
$20
Ardelyx, Inc.
$20
Philips Electronics North America Corporation
$20
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AJOVY · ANORO ELLIPTA · APTIMA · Aimovig · Azstarys · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BRINTELLIX · BRIXADI · BYDUREON · Belbuca · CAMZYOS · CAPLYTA · CREON · Cologuard Collection Kit · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · GATTEX · GEMTESA · GIMOTI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · Horizant · IBSRELA · INGREZZA · INJECTAFER · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LOKELMA · LOREEV XR · LYBALVI · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Movantik · Myrbetriq · NURTEC ODT · NUZYRA · Otezla · Ozempic · PENNSAID · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · REXULTI · RYBELSUS · Rybelsus · SEGLENTIS · SHINGRIX · STIOLTO RESPIMAT · SUBLOCADE · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · TEPEZZA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · UBRELVY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAMAX · VYVANSE · Vascepa · Veozah · XARELTO · XIFAXAN · XTAMPZA · Xofluza · ZENPEP · ZORYVE · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in PA.

Looking for a nurse practitioner - family in Philadelphia?
Compare family nurse practitioners in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
2,245
Per 100K population
141.9
County median income
$60,698
Nearest hospital
MALVERN BEHAVIORAL HEALTH
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Renzi is a clinical cardiology specialist, with above-average Medicare volume (top 10% in PA), with low-engagement industry engagement in the top 1% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Renzi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Renzi performed 491 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Renzi receive payments from pharmaceutical companies?
Yes. Dr. Renzi received a total of $13,672 from 61 companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Renzi's costs compare to other family nurse practitioners in Philadelphia?
Dr. Renzi's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Renzi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →